← Insider buys
RLAY

Relay Therapeutics, Inc. · Healthcare

President and CEO Sanjiv Patel sold $913K of Relay Therapeutics, Inc.

Sold$912,889
$18.94Price
48,199Shares
−8%Stake

What RLAY did after the filing

Filed Sep 9Copier in Sep 10
The stock from Thu, Sep 10 open, $18.30
−6.8%
S&P 500, same days
+1.5%

24 of 30 trading days so far, to the Oct 14 close.

Traded Tue, Sep 8. Filed Wed, Sep 9, 4:12 PM ET, after the close. Returns use the Sep 10 open and the Oct 14 close. Not investment advice.